Advancing HIV prevention demonstration projects: new strategies for a changing epidemic.

Autor: Heffelfinger JD, Sullivan PS, Branson BM, Mastro TD, Purcell DW, Griffiths SD, Romaguera RA, Janssen RS

Publikováno v: Public Health Reports; Nov/Dec2008 Supplement, Vol. 123, p5-15, 11p

FDA, CDC, and NIH Co-sponsored Public Workshop Summary-Development Considerations of Antimicrobial Drugs for the Treatment of Gonorrhea.

Autor: Hiruy H; Division of Anti-Infectives, Office of Infectious Diseases, Office of New Drugs, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, MD., Bala S; Division of Anti-Infectives, Office of Infectious Diseases, Office of New Drugs, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, MD., Byrne JM; Office of Infectious Diseases, Office of New Drugs, CDER, FDA, Silver Spring, MD., Roche KG; Division of Anti-Infectives, Office of Infectious Diseases, Office of New Drugs, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, MD., Jang SH; Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, Office of Translational Sciences, CDER, FDA, Silver Spring, MD., Kim P; Division of Anti-Infectives, Office of Infectious Diseases, Office of New Drugs, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, MD., Nambiar S; Division of Anti-Infectives, Office of Infectious Diseases, Office of New Drugs, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, MD., Rubin D; Division of Biometrics IV, Office of Biostatistics, Office of Translational Sciences, CDER, FDA, Silver Spring, MD., Yasinskaya Y; Division of Anti-Infectives, Office of Infectious Diseases, Office of New Drugs, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, MD., Bachmann LH; Division of STD Prevention, National Center for HIV/AIDs, Viral Hepatitis, STD and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC), Atlanta, GA., Bernstein K; Division of STD Prevention, NCHHSTP, CDC, Atlanta, GA., Botgros R; European Medicines Agency, Amsterdam, The Netherlands., Cammarata S; Melinta Therapeutics, Parsippany, NJ., Chaves RL; Debiopharm International SA, Lausanne, Switzerland., Deal CD; Enteric and Sexually Transmitted Infections Branch, Division of Microbiology and Infectious Diseases (DMID), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD., Drusano GL; Institute for Therapeutic Innovation, College of Medicine, University of Florida, Lake Nona, FL., Duffy EM; Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), Boston University, Boston, MA., Eakin AE; Office of Biodefense, Research Resources & Translational Research, DMID, NIAID, NIH, Bethesda, MD., Gelone S; Nabriva Therapeutics plc, Fort Washington, PA., Hiltke T; Enteric and Sexually Transmitted Infections Branch, DMID, NIAID, NIH, Bethesda, MD., Hook Iii EW; Department of Medicine, The University of Alabama at Birmingham, Birmingham, AL., Jerse AE; Department of Microbiology and Immunology, Uniformed Services University, Bethesda, MD., McNeil CJ; Department of Medicine, Section on Infectious Diseases, Wake Forest University School of Medicine, Southeast STD/HIV PTC, Forsyth County Department of Public Health, and North Carolina Strengthening the United States Response to Resistant Gonorrhea, Winston-Salem, NC., Newman L; Enteric and Sexually Transmitted Infections Branch, DMID, NIAID, NIH, Rockville, MD., O'Brien S; Global Antibiotic Research & Development Partnership (GARDP), Geneva, Switzerland., Perry C; GlaxoSmithKline, Collegeville, PA., Reno HEL; Washington University School of Medicine in St. Louis, St. Louis STD/HIV Prevention Training Center, St. Louis STI Regional Response Coalition, St. Louis, MO., Romaguera RA; Division of STD Prevention, NCHHSTP, CDC, Atlanta, GA., Sato J; Pharmaceuticals and Medical Devices Agency (PMDA) Tokyo, Japan., Unemo M; WHO Collaborating Centre for Gonorrhea and Other STIs, Örebro University, Örebro, Sweden., Wi TEC; Global HIV, Hepatitis and STIs Programmes, World Health Organization (WHO), Geneva, Switzerland., Workowski K; Division of Infectious Diseases, Emory University, Atlanta, GA., O'May GA; DRT Strategies, Inc., 1001 19th Street N, Suite 1200, Arlington, VA., Shukla SJ; Office of Infectious Diseases, Office of New Drugs, CDER, FDA, Silver Spring, MD., Farley JJ; Office of Infectious Diseases, Office of New Drugs, CDER, FDA, Silver Spring, MD.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Jul 24. Date of Electronic Publication: 2024 Jul 24.

The Spatial Association Between Federally Qualified Health Centers and County-Level Reported Sexually Transmitted Infections: A Spatial Regression Approach.

Autor: Owusu-Edusei K Jr; From the Centers for Disease Control Prevention, Atlanta, GA., Gift TL, Leichliter JS, Romaguera RA

Publikováno v: Sexually transmitted diseases [Sex Transm Dis] 2018 Feb; Vol. 45 (2), pp. 81-86.

Hispanic Men in the United States: Acculturation and Recent Sexual Behaviors With Female Partners, 2006-2010.

Autor: Haderxhanaj LT; Laura T. Haderxhanaj, Raul A. Romaguera, Fred R. Bloom, and Jami S. Leichliter are with the Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Scott D. Rhodes is with the Division of Public Health Services, School of Medicine, Wake Forest University, Winston-Salem, NC., Rhodes SD; Laura T. Haderxhanaj, Raul A. Romaguera, Fred R. Bloom, and Jami S. Leichliter are with the Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Scott D. Rhodes is with the Division of Public Health Services, School of Medicine, Wake Forest University, Winston-Salem, NC., Romaguera RA; Laura T. Haderxhanaj, Raul A. Romaguera, Fred R. Bloom, and Jami S. Leichliter are with the Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Scott D. Rhodes is with the Division of Public Health Services, School of Medicine, Wake Forest University, Winston-Salem, NC., Bloom FR; Laura T. Haderxhanaj, Raul A. Romaguera, Fred R. Bloom, and Jami S. Leichliter are with the Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Scott D. Rhodes is with the Division of Public Health Services, School of Medicine, Wake Forest University, Winston-Salem, NC., Leichliter JS; Laura T. Haderxhanaj, Raul A. Romaguera, Fred R. Bloom, and Jami S. Leichliter are with the Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Scott D. Rhodes is with the Division of Public Health Services, School of Medicine, Wake Forest University, Winston-Salem, NC.

Publikováno v: American journal of public health [Am J Public Health] 2015 Aug; Vol. 105 (8), pp. e126-33. Date of Electronic Publication: 2015 Jun 11.

Special supplement on Hispanics/Latinos and HIV/AIDS. Introduction.

Autor: Stallworth JM; Capacity Building Branch, Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention (CDC), Atlanta, GA 30333, USA. jstallworth@cdc.gov, Herbst JH, Alvarez ME, Romaguera RA, Amaro H, Dean HD

Publikováno v: AIDS education and prevention : official publication of the International Society for AIDS Education [AIDS Educ Prev] 2009 Oct; Vol. 21 (5 Suppl), pp. 3-6.